Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs

Antimicrobial resistance, the so-called silent pandemic, is pushing industry and academia to find novel antimicrobial agents with new mechanisms of action in order to be active against susceptible and drug-resistant microorganisms. In the case of tuberculosis, the need of novel anti-tuberculosis dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquerra-Aznárez, José Manuel, Almeida da Silva, Pedro E., Aínsa, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622410/
https://www.ncbi.nlm.nih.gov/pubmed/34835459
http://dx.doi.org/10.3390/microorganisms9112335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622410/
https://www.ncbi.nlm.nih.gov/pubmed/34835459
http://dx.doi.org/10.3390/microorganisms9112335

Ejemplares similares